Work

Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

Year: 2020

Type: review

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.1782

Authors: Daniela J. Conrado, Sridhar Duvvuri, Hugo Geerts, Jackson Burton, Carla Biesdorf, Malidi Ahamadi, Sreeraj Macha, Gregory Hather, Juan Francisco Morales, Jagdeep Podichetty, Timothy Nicholas, Diane Stephenson, Mirjam Trame, Klaus Romero, Brian Corrigan, the Drug Development Tools in the Alzheimer Disease Continuum (DDT‐AD) Working Group

Institutions: Cerevel Therapeutics (United States), In Silico Biosciences (United States), Critical Path Institute, Indiana University Indianapolis, Merck & Co., Inc., Rahway, NJ, USA (United States), Sanofi (United States), Universidad Nacional de La Plata, Pfizer (United States)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Food and Drug Administration

Award: G1747133292

OpenAlex ID: W2999083560

FWCI: 0.47

Cites: 89

Cited by: 21

Related to: 10